Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection (injection) from Hospira, Inc., A Pfizer Company with status Current. The shortage was first posted on Feb 20, 2018. Reported reason: Other
Shortage details
- Status
- Current
- Company
- Hospira, Inc., A Pfizer Company
- Package NDC
- 0409-9043-01
- Dosage Form
- Injection
- Presentation
- Bupivacaine Hydrochloride with Epinephrine, Injection, 125 mg/50 mL (2.5 mg/mL) (NDC 0409-9043-01)
- Initial Posting
- Feb 20, 2018
Reason
Other